产品中心 抗体 其他一抗

所有图片(1/7)

CD59 Mouse mAb (S-936-1)

CD59 glycoprotein,1F5 antigen,20 kDa homologous restriction factor (HRF-20,HRF20),MAC-inhibitory protein (MAC-IP),MEM43 antigen,Membrane attack complex inhibition factor (MACIF),MIC11,MIN1,MIN2,MIN3,MSK21

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B6022
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    CD59
  • 分子别名

    CD59 glycoprotein; 1F5 antigen; 20 kDa homologous restriction factor (HRF-20; HRF20); MAC-inhibitory protein (MAC-IP); MEM43 antigen; Membrane attack complex inhibition factor (MACIF); MIC11; MIN1; MIN2; MIN3; MSK21
  • 免疫原

    Recombinant Protein
  • 细胞定位

    Cell membrane, Secreted
  • Accession

    P13987
  • 克隆号

    S-936-1
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG1,k
  • 反应种属 ?

    Hu
  • 阳性样本

    HeLa, HT-1080, U-87 MG, HT-29
  • 纯化方式

    Protein G
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    IHC-P ?

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000 Hu
    IHC-P 1:2000 Hu
背景介绍
  • CD59, also known as protectin or membrane attack complex inhibitory factor (MACIF), is a glycosylphosphatidylinositol (GPI)-anchored membrane protein that plays a crucial role in regulating the complement system. It is widely expressed in most human tissues and acts as a major inhibitor of the membrane attack complex (MAC) formation. The mature CD59 protein consists of 77 amino acids and is anchored to the cell membrane via a GPI anchor. By binding to complement proteins C8 and C9, CD59 prevents the assembly of the MAC, thereby protecting host cells from complement-mediated lysis. Deficiencies in CD59 expression can lead to serious disorders such as paroxysmal nocturnal hemoglobinuria (PNH), characterized by the destruction of red blood cells. Additionally, CD59 is involved in T cell signal transduction and has been implicated in various diseases, including cancer and autoimmune disorders.

  • 免疫印迹

    • WB result of CD59 Mouse mAb
      Primary antibody: CD59 Mouse mAb at 1/1000 dilution
      Lane 1: Raji whole cell lysate 20 µg
      Lane 2: HeLa whole cell lysate 20 µg
      Lane 3: HT-1080 whole cell lysate 20 µg
      Lane 4: U-87 MG whole cell lysate 20 µg
      Lane 5: HT-29 whole cell lysate 20 µg
      Negative control: Raji whole cell lysate
      Secondary antibody: Goat Anti-mouse IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 14 kDa
      Observed MW: 17-24 kDa

  • 免疫组化

    • IHC shows positive staining in paraffin-embedded human tonsil. Anti-CD59 antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human placenta. Anti-CD59 antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human hepatocellular carcinoma. Anti-CD59 antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human endometrial cancer. Anti-CD59 antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

  • 组织表达图谱

    • Expression of CD59 in tumor tissue.

    • Expression of CD59 in human tissue.

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)